FDA Approves Single-Dose $1125 a Pill Hepatitis C Cure as Breakthrough Drug

October 11, 2014 6:34 AM

17 0

By Katie Mayangi, October 10th, 2014 | One Comment

A new drug named Harvoni to treat chronic hepatitis C virus genotype 1 infection (HCV) has been approved by the Food and Drug Administration (FDA), but it comes with a hefty $1125 a pill cost. That means a 12 week regimen will cost $94,500, although it’s anticipated that a good number of patients wi...

Read more

To category page